laboratori corpor america hold
first look second-quart result larg guidanc narrow
confer call held thursday juli et updat model
estim confer call dial-in passcod
revenu billion miss billion target street billion
diagnost lcd billion miss billion target
covanc cdd billion miss billion target
adjust ep beat target consensu
return equiti ttm
manag narrow outlook revenu expect grow
inclus headwind divestitur headwind
currenc compar previou rang includ
headwind divestitur adjust ep expect
previou rang free cash flow expect million
labcorp second-largest independ clinic laboratori unit state nation network
primari laboratori patient servic center compani perform routin laboratori test
specimen day built lead platform esoter test
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
lcd outlook narrow higher end rang revenu expect includ fx
headwind basi point neg impact divestitur compar previou rang
pama headwind lcd revenu growth second quarter compar full-year
guidanc basi point
cdd outlook narrow revenu expect grow includ fx headwind unchang
compar previou rang
updat model follow today confer call current model call revenu
billion adjust ep
stock share sit time adjust ep target three-year averag time view
remain compel long-term entri point continu believ compani effort build scale diversifi
cro busi leverag labcorp broad patient access lead higher revenu growth case
covanc independ diagnost side intrigu potenti rapidli grow walgreen
collabor continu believ earli inning secular shift market share lower-cost larger lab
given medicar reimburs pressur increas effort part privat payer reduc lab spend strateg
way compani deliv solid execut year-to-d despit face steepest year pama cut share
loss expect investor continu get comfort ep rang long-term growth outlook
maintain outperform rate
